116 related articles for article (PubMed ID: 96136)
1. Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder.
Lopaciuk S; Bykowska K; McDonagh JM; McDonagh RP; Yount WJ; Fuller CR; Cooperstein L; Gray A; Lorand L
J Clin Invest; 1978 May; 61(5):1196-203. PubMed ID: 96136
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system.
Lorand L; Velasco PT; Rinne JR; Amare M; Miller LK; Zucker ML
Proc Natl Acad Sci U S A; 1988 Jan; 85(1):232-6. PubMed ID: 3422419
[TBL] [Abstract][Full Text] [Related]
3. Acquired plasma factor XIII deficiencies.
Tosetto A; Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):5-10. PubMed ID: 8039759
[TBL] [Abstract][Full Text] [Related]
4. Generation and mechanism of action of a potent inhibitor of factor XIII function.
Reed GL; Lukacova D
Thromb Haemost; 1995 Aug; 74(2):680-5. PubMed ID: 8585006
[TBL] [Abstract][Full Text] [Related]
5. [Acquired inhibitors (autoantibodies) to coagulation factors in non-hemophilic patients].
Okamura T; Tsuda H
Rinsho Ketsueki; 1993 May; 34(5):583-7. PubMed ID: 7686235
[TBL] [Abstract][Full Text] [Related]
6. Preferential association of kappa IIIb light chains with monoclonal human IgM kappa autoantibodies.
Ledford DK; Goñi F; Pizzolato M; Franklin EC; Solomon A; Frangione B
J Immunol; 1983 Sep; 131(3):1322-5. PubMed ID: 6193185
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of factor XIII activation by an anti-peptide monoclonal antibody.
Lukacova D; Matsueda GR; Haber E; Reed GL
Biochemistry; 1991 Oct; 30(42):10164-70. PubMed ID: 1681898
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune antibody in a hemorrhagic patient interacts with thrombin-activated factor XIII in a unique manner.
Lorand L; Velasco PT; Murthy SN; Lefebvre P; Green D
Blood; 1999 Feb; 93(3):909-17. PubMed ID: 9920840
[TBL] [Abstract][Full Text] [Related]
9. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
[TBL] [Abstract][Full Text] [Related]
10. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: effects on blood coagulation, protein C activation and platelet function.
Chouhan VD; De La Cadena RA; Nagaswami C; Weisel JW; Kajani M; Rao AK
Thromb Haemost; 1997 Feb; 77(2):343-9. PubMed ID: 9157594
[TBL] [Abstract][Full Text] [Related]
12. IgGs containing λ- and κ-type light chains and of all subclasses (IgG1-IgG4) from the sera of patients with autoimmune diseases and viral and bacterial infections hydrolyze DNA.
Parkhomenko TA; Buneva VN; Doronin BM; Volkova MV; Senkovich SA; Generalov II; Nevinsky GA
J Mol Recognit; 2012 Jul; 25(7):383-92. PubMed ID: 22733547
[TBL] [Abstract][Full Text] [Related]
13. A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA.
Fukue H; Anderson K; McPhedran P; Clyne L; McDonagh J
Blood; 1992 Jan; 79(1):65-74. PubMed ID: 1370210
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation.
Lorand L; Urayama T; De Kiewiet JW; Nossel HL
J Clin Invest; 1969 Jun; 48(6):1054-64. PubMed ID: 4977030
[TBL] [Abstract][Full Text] [Related]
15. Aggressive fatal case of autoimmune hemorrhaphilia resulting from anti-Factor XIII antibodies.
Sugiyama H; Uesugi H; Suzuki S; Tanaka K; Souri M; Ichinose A
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):85-9. PubMed ID: 23183237
[TBL] [Abstract][Full Text] [Related]
16. Factor XIII Deficiency.
Karimi M; Bereczky Z; Cohan N; Muszbek L
Semin Thromb Hemost; 2009 Jun; 35(4):426-38. PubMed ID: 19598071
[TBL] [Abstract][Full Text] [Related]
17. Haemorrhagic syndrome of autoimmune origin with a specific inhibitor against fibrin stabilizing factor (factor XIII).
Lorand L; Maldonado N; Fradera J; Atencio AC; Robertson B; Urayama T
Br J Haematol; 1972 Jul; 23(1):17-27. PubMed ID: 5045959
[No Abstract] [Full Text] [Related]
18. An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme.
Sié P; Bezeaud A; Dupouy D; Archipoff G; Freyssinet JM; Dugoujon JM; Serre G; Guillin MC; Boneu B
J Clin Invest; 1991 Jul; 88(1):290-6. PubMed ID: 1711542
[TBL] [Abstract][Full Text] [Related]
19. Antibody-induced acute factor X deficiency: clinical manifestations and properties of the antibody.
Rao LV; Zivelin A; Iturbe I; Rapaport SI
Thromb Haemost; 1994 Sep; 72(3):363-71. PubMed ID: 7855785
[TBL] [Abstract][Full Text] [Related]
20. The immunological characterization of human antibodies to factor VIII isolated by immuno-affinity chromatography.
Kavanagh ML; Wood CN; Davidson JF
Thromb Haemost; 1981 Feb; 45(1):60-4. PubMed ID: 6787728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
